Boothbay Fund Management’s Biohaven BHVN Stock Holding History

Boothbay Fund Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-301,000	Closed	-$4.52M	–	1978
2025 Q3	$4.52M	Buy	301,000 +197,600	+191%	+$2.88M	0.07%	336
2025 Q2	$1.46M	Sell	103,400 -6,500	-6%	-$116K	0.03%	575
2025 Q1	$2.64M	Buy	+109,900	New	+$3.88M	0.07%	367
2024 Q2	–	Sell	-62,200	Closed	-$3.4M	–	1533
2024 Q1	$3.4M	Buy	+62,200	New	+$3.08M	0.07%	335
2023 Q3	–	Sell	-45,100	Closed	-$1.08M	–	1741
2023 Q2	$1.08M	Buy	+45,100	New	+$776K	0.02%	795

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boothbay Fund Management's BHVN Position: Q1 2026 in Review

Boothbay Fund Management increased its Biohaven (BHVN) stake by 75% in Q1 2026, buying an estimated $599K and bringing the position to 127,862 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #903.

Boothbay Fund Management first reported a position in BHVN in Q4 2022 and has held it in 6 quarters since. The position peaked at $2.09M in Q4 2022. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Boothbay Fund Management held 127,862 shares of Biohaven worth $1.08M as of Q1 2026.
Boothbay Fund Management bought 54,785 Biohaven shares in Q1 2026, an estimated $599K.
Biohaven made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #903 holding.
Boothbay Fund Management first reported a position in Biohaven in Q4 2022 and has held it in 6 quarters since.
Boothbay Fund Management's Biohaven position peaked at $2.09M in Q4 2022.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.